To utilize hepatocytes for insulin-producing surrogate cells, also observed with glucagon and IBMX. Production was we devised a regulatory secretion system by placing proinaugmented two-fold by the addition of wortmannin, a sulin DNA under the regulatable promoter for phosphoenolphosphatidylinositol (PI)-3-kinase inhibitor, suggesting pyruvate carboxykinase (PEPCK). The expression of that inhibitory insulin signaling to the PEPCK promoter PEPCK is down-regulated by insulin, and up-regulated by may be mediated through PI-3-kinase. Addition of cAMP and glucagon. To express insulin in hepatocytes, we exogenous insulin to the culture decreased insulin constructed an adenoviral insulin expression system. After mRNA expression remarkably on Northern blot. Thus, infection, the hepatocytes secreted immunoreactive insulin by using a PEPCK promoter for insulin expression, we (IRI) at an increasing rate. IRI secretion increased over were able to up-regulate insulin production from hepatofour-fold upon stimulation with 300 M cAMP and 500 M cytes with cAMP and glucagon, and down-regulate with of the cAMP-dependent phosphodiesterase inhibitor 3-insulin itself. isobutyl-1-methylxanthine (IBMX). This increase was